Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04536480 · ClinicalTrials.gov registry record · NA
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)
A NA study of Type 2 Diabetes and Pediatric Obesity, sponsored by Children's Hospital Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04536480: Recruiting NA study of Type 2 Diabetes and Pediatric Obesity, sponsored by Children's Hospital Los Angeles.
NCT04536480 is a NA study of Type 2 Diabetes and Pediatric Obesity that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 100 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04536480, a NA study of Type 2 Diabetes and Pediatric Obesity, is actively recruiting participants, sponsored by Children's Hospital Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To find the effectiveness of a diet plan (Time Limited Eating or TLE) on glycemic control, B-cell function, body fat, and body mass index (BMI) in adolescents with type 2 diabetes.
Primary Outcome
Change in percent time in range, as measured on CGM over the study period
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitor
- BEHAVIORAL Control
- BEHAVIORAL Time Limited Eating
- BEHAVIORAL Components Common to All Study Arms.
Study Locations (1)
California
- Children's Hospital of Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-04-15 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
What NCT04536480 shows while recruiting
NCT04536480 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 4 interventions - of which Continuous Glucose Monitor is the first listed.
NCT04536480 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04536480 about?
NCT04536480 is a clinical study titled "Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)". To find the effectiveness of a diet plan (Time Limited Eating or TLE) on glycemic control, B-cell function, body fat, and body mass index (BMI) in adolescents with type 2 diabetes.
What is the current status of trial NCT04536480?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-15. Estimated completion is 2027-12-01.
What conditions does trial NCT04536480 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Pediatric Obesity, Time-restricted Eating.
What interventions are being tested in trial NCT04536480?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE), Control (BEHAVIORAL), Time Limited Eating (BEHAVIORAL), Components Common to All Study Arms. (BEHAVIORAL).
Who is sponsoring clinical trial NCT04536480?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04536480 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04536480's enrollment target sits among peer trials
100 152nd of 327 higher than 166 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI